Literature DB >> 28493028

Every cloud has a silver lining.

Filippo Pieralli1, Silvia Baroncelli2, Alberto Farese3, Antonio Mancini1, Fabio Luise1, Lucia Sammicheli1, Alessandro Bartoloni3, Gian Maria Rossolini4,5, Carlo Nozzoli6.   

Abstract

Keywords:  Colistin; Fosfomycin; Meropenem; Micafungin; Tigecycline

Mesh：

Substances：

Year:  2017        PMID： 28493028     DOI： 10.1007/s11739-017-1675-z

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  18 in total

Review 1.  Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections.

Authors:  Marco Falcone; David Paterson
Journal:  J Antimicrob Chemother       Date:  2016-07-17       Impact factor: 5.790

2.  Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae.

Authors:  Catharine C Bulik; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

3.  Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae.

Authors:  Helen Giamarellou; Lambrini Galani; Fotini Baziaka; Ilias Karaiskos
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

4.  Clinical characteristics and outcomes of patients with extended-spectrum β-lactamase-producing bacteremias in the emergency department.

Authors:  Jiun-Nong Lin; Yen-Hsu Chen; Lin-Li Chang; Chung-Hsu Lai; Hsing-Lin Lin; Hsi-Hsun Lin
Journal:  Intern Emerg Med       Date:  2011-10-28       Impact factor: 3.397

5.  Pathways Regulating the pbgP Operon and Colistin Resistance in Klebsiella pneumoniae Strains.

Authors:  Myung-Jin Choi; Sunju Kim; Kwan Soo Ko
Journal:  J Microbiol Biotechnol       Date:  2016-09-28       Impact factor: 2.351

6.  First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate.

Authors:  Romney M Humphries; Shangxin Yang; Peera Hemarajata; Kevin W Ward; Janet A Hindler; Shelley A Miller; Aric Gregson
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

7.  Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae.

Authors:  Yin Yuhan; Yue Ziyun; Zhang Yongbo; Li Fuqiang; Zhang Qinghua
Journal:  Rev Soc Bras Med Trop       Date:  2016-04       Impact factor: 1.581

8.  The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.

Authors:  Michael J Satlin; Stephen G Jenkins; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2014-01-23       Impact factor: 9.079

9.  Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae.

Authors:  Carlo Tascini; Enrico Tagliaferri; Tommaso Giani; Alessandro Leonildi; Sarah Flammini; Beatrice Casini; Russell Lewis; Simone Ferranti; Gian Maria Rossolini; Francesco Menichetti
Journal:  Antimicrob Agents Chemother       Date:  2013-06-10       Impact factor: 5.191

10.  Mapping the Evolution of Hypervirulent Klebsiella pneumoniae.

Authors:  Carsten Struve; Chandler C Roe; Marc Stegger; Steen G Stahlhut; Dennis S Hansen; David M Engelthaler; Paal S Andersen; Elizabeth M Driebe; Paul Keim; Karen A Krogfelt
Journal:  MBio       Date:  2015-07-21       Impact factor: 7.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.